Skip to main content
. 2024 Oct 7;56(1):2409343. doi: 10.1080/07853890.2024.2409343

Table 1A.

Multivariate logistic regression analysis of HER2 ­status (change versus not change) among patients with HER2-low tumours before neoadjuvant therapy.

Characteristics OR 95%CI p Value
Hormone receptor (positive versus negative) 0.067 0.007–0.654 .020
Ki-67 (>30% versus ≤30%) 1.705 0.546–5.329 .359

Abbreviations: HER2, human epidermal growth factor receptor 2; OR, odds ratio; CI, ­confidence interval. 

Note: Bold values indicate statistical significance.